Old Web
English
Sign In
Acemap
>
Paper
>
905P FIH phase I dose escalation and dose expansion study of anti-EGFR ADC MRG003 in patients with advanced solid tumors
905P FIH phase I dose escalation and dose expansion study of anti-EGFR ADC MRG003 in patients with advanced solid tumors
2021
M. Qiu
Y. Guo
W Guo
W Nian
W Liao
Z. Xu
W. Zhang
Y Zhang
X. Wei
L Xue
W. Tang
Y. Wu
G … Ren
L. Wang
J. Xi
Y. Wang
M. Li
F. Hausheer
C Hu
R. Xu
Keywords:
in patient
Oncology
Internal medicine
dose escalation
Phase (matter)
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]